K

Kadimastem Ltd
TASE:KDST

Watchlist Manager
Kadimastem Ltd
TASE:KDST
Watchlist
Price: 2 794 ILS -1.13% Market Closed
Market Cap: 117.9m ILS

Net Margin
Kadimastem Ltd

0%
Current
0%
Average
-6.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-26.6m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Kadimastem Ltd
Glance View

Market Cap
117.9m ILS
Industry
Biotechnology

Kadimastem Ltd. is a clinical-stage bio-pharmaceutical company engaging in the development of industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells to treat neurology-degenerative diseases. The Company’s technology enables the differentiation of stem cells into insulin secreting beta cells, as well as a range of neural cells (including Oligodendrocytes, Astrocytes). The firm produces islet-like clusters that show glucose-stimulated insulin secretion. In addition, the Company is partnering with pharmaceutical companies interested to screen potential drug compounds (hit-lead, lead optimization) on its stem-cell derived cells, primarily oligodendrocytes and astrocytes.

KDST Intrinsic Value
Not Available
K
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-26.6m
/
Revenue
0
What is the Net Margin of Kadimastem Ltd?

Based on Kadimastem Ltd's most recent financial statements, the company has Net Margin of 0%.

Back to Top